NCT03626597

Brief Summary

Kenyan families experience persistently high rates of maternal and neonatal mortality, which disproportionately affects women with low income and education and those who live far from health services. Key proven interventions include prevention of pregnancy and birth spacing, early entry to antenatal care, and facility delivery. However, creative, cost-effective interventions are urgently needed to link particularly vulnerable populations with these important health services. Previous research has shown that equipping community health volunteers (CHVs) with a tool as simple as a urine pregnancy test and training to provide post-test counseling is effective in improving linkages to antenatal care and family planning services. The invesitgators' proposal includes a multi-phase process to collect qualitative data through a needs assessment (Phase 1), use community input to develop (Phase 2) and implement a pilot intervention study (Phase 3) assessing the ability of CHV-based provision of urine pregnancy tests with CHV-provided and phone-based post-test counseling to link women with antenatal care and family planning services, and collect qualitative program evaluation data (Phase 4). This will provide much-needed information for how to effectively utilize and strengthen CHVs as part of a sustainable reproductive health care delivery system to improve maternal and neonatal mortality. The broad objectives are to determine whether the use of community-based provision of urine pregnancy tests with post-test counseling and referral to care is acceptable to community health volunteers (CHVs) and participants and to determine which method of post-test counseling and referral to care, CHV-provided or phone-based, is more acceptable and more effective. Participant outcomes, including the primary outcome of utilization of ANC or family planning care, will be measured by telephone questionnaires one to three months post-enrollment. CHV outcomes will be determined by telephone questionnaires as well as review of CHV log books.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
308

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 13, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

October 13, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

July 29, 2018

Last Update Submit

December 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Utilization of care

    Defined as proportion of participants who self-report attendance to at least one Antenatal Care (ANC) visit for women with positive UPT or Family Planning (FP) clinic visit for women with negative UPT

    1-3 months post-enrollment

Secondary Outcomes (8)

  • Participant Satisfaction with CHV-based UPT provision

    1-3 months post-enrollment

  • Participant preference for CHV-based vs phone-based post-test counseling and referral

    At the time of enrollment

  • Number of UPTs provided per month

    Monthly, thoughout the study period (estimated 10 months)

  • CHV comfort with UPT provision and post-test counseling and referral

    At the time of time of UPT provision

  • Participant utilization of phone-based post-test counseling and referral

    1-3 months post-enrollment

  • +3 more secondary outcomes

Study Arms (2)

CHV-provided post-test counseling & referral

ACTIVE COMPARATOR

The CHV will provide the woman with the urine pregnancy test and collect baseline information. If the woman desires enrollment in Arm 1 (CHV-provided post-test counseling and referral), the CHV will provide all post-test counseling and referral based on training provided. This may occur at the time of enrollment or at a later time, as preferred by the woman.

Diagnostic Test: Urine Pregnancy TestBehavioral: CHV-based post-test counseling & referral

Phone-based post-test counseling & referral

ACTIVE COMPARATOR

The CHV will provide the woman with the urine pregnancy test and collect baseline information. If the woman desires enrollment in Arm 2 (phone-based post-test counseling and referral), the CHV will provide the woman with a phone number which she may call or short message service (SMS) to receive post-test counseling and referral. If the study team does not receive a call or SMS from the woman within one week, our research assistant will phone and/or SMS the participant to provide phone-based post-test counseling and referral.

Diagnostic Test: Urine Pregnancy TestBehavioral: Phone-based post-test counseling & referral

Interventions

Urine Pregnancy TestDIAGNOSTIC_TEST

CHV will provide all participants with in-person urine pregnancy tests (UPTs)

CHV-provided post-test counseling & referralPhone-based post-test counseling & referral

CHVs will provide in-person post-test counseling \& referral to care

CHV-provided post-test counseling & referral

Participants will call/SMS or be called/SMSed for phone-based counseling \& referral to care

Phone-based post-test counseling & referral

Eligibility Criteria

Age15 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParticipants must self-represent as female
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Approved and designated CHV by their respective county

You may not qualify if:

  • Women participants:
  • Women aged 15-45, inclusive
  • Desire to use a urine pregnancy test for any reason.
  • Have availability of a phone.
  • Agree to enrollment in the study and to be contacted for data collection
  • Conversant in Kiswahili or English
  • Physical or mental illness that precludes study involvement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moi University/MTRH

Eldoret, 30100, Kenya

Location

MeSH Terms

Conditions

Contraception BehaviorPregnancy Complications

Interventions

Referral and Consultation

Condition Hierarchy (Ancestors)

Reproductive BehaviorBehaviorFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Parallel, non-blinded, patient preference model.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Obstetrics & Gynecology

Study Record Dates

First Submitted

July 29, 2018

First Posted

August 13, 2018

Study Start

October 13, 2018

Primary Completion

September 1, 2019

Study Completion

November 30, 2019

Last Updated

December 17, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations